Faculty profile
Deborah Marcellus
Back to facultyResearch
Research areas are derived from OpenAlex topics of their publications.
70 publications.
Canadian Cancer Trials Group (CCTG) LY.17: A Randomized Phase II Study Evaluating Novel Salvage Therapy Pre-Autologous Stem Cell Transplant (ASCT) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (RR-DLBCL) - Outcome of Rituximab-Dose-Intensive Cyclophosphamide, Etoposide, Cisplatin (R-DICEP) Versus R-GDP
Stewart DA, Shepherd LE, Dudebout JJ, Larouche J-F, Chua N, Baetz T, Crump M, Shafey M, Abdel-Samad N, Robinson S
Outcomes of MYC‐associated lymphomas after R‐CHOP with and without consolidative autologous stem cell transplant: subset analysis of randomized trial intergroup SWOG S9704
Puvvada SD, Stiff PJ, Leblanc M, Cook JR, Couban S, Leonard JP, Kahl B, Marcellus D, Shea TC, Winter JN
Autologous Transplantation As Consolidation for High Risk Aggressive T-Cell Non-Hodgkin's Lymphoma: A SWOG S9704 Intergroup Trial Subgroup Analysis
Stiff PJ, Li H, Cook JR, Constine LS, Couban S, Stewart DA, Shea TC, Porcu P, Winter JN, Kahl BS
Autologous Transplantation as Consolidation for Aggressive Non-Hodgkin's Lymphoma
Couban S, Shea TC, Miller TP, Tubbs RR, Marcellus D, Barton KP, Mills GM, Fisher RI, Unger JM, Cook JR
A randomized phase 3 trial of thalidomide and prednisone as maintenance therapy after ASCT in patients with MM with a quality-of-life assessment: the National Cancer Institute of Canada Clinicals Trials Group Myeloma 10 Trial
Stewart AK, Trudel S, Bahlis NJ, White D, Sabry W, Belch A, Reiman T, Roy J, Shustik C, Kovacs MJ
Lenalidomide Plus Melphalan Without Prednisone for Previously Untreated Older Patients With Multiple Myeloma: A Phase II Trial
White DJ, Bahlis NJ, Marcellus DC, Belch A, Stewart AK, Chen C, Kovacs MJ, Macdonald DA, Reece DE, Reiman T
Randomized phase III U.S./Canadian intergroup trial (SWOG S9704) comparing CHOP ± R for eight cycles to CHOP ± R for six cycles followed by autotransplant for patients with high-intermediate (H-Int) or high IPI grade diffuse aggressive non-Hodgkin lymphoma (NHL).
Stiff PJ, Unger JM, Cook J, Constine LS, Couban S, Shea TC, Winter JN, Miller TP, Tubbs RR, Marcellus DC
Comparison of Comorbidity Scores and the Impact of Comorbidities on Length of Stay and Survival in Patients with Non−Hodgkin’s Lymphoma Treated with Autologous Stem Cell Transplant
Lepic K, Benger A, Foley R, Fraser G, Marcellus D, Saunders-Roy M, Trus M, Adams A, Kolm K, Wiernikowski J
Comparison of Comorbidity Scores and the Impact of Comorbidities on Length of Stay and Survival in Patients with Non-Hodgkin's Lymphoma Treated with Autologous Stem Cell Transplant
Lepic K, Benger A, Foley R, Fraser G, Marcellus D, Saunders-Roy M, Trus M, Adams A, Kolm K, Wiemikowski J
Determining Patterns of Therapy Choice in Patients Treated for Early Stage, Aggressive Histology Non-Hodgkin's Lymphoma
Swaminath A, Kouroukis T, Voruganti S, Sagar S, Marcellus D, Benger A, Foley R, Trus M, Fraser G, Sussman J
Frequent collaborators
12Researchers with similar interests
Tom Kouroukis
Oncology
Lymphoma Diagnosis and Treatment, Multiple Myeloma Research and Treatments
Amaris Karin Balitsky
Oncology
Multiple Myeloma Research and Treatments, Lymphoma Diagnosis and Treatment
Hira Mian
Oncology
Multiple Myeloma Research and Treatments, Cancer Treatment and Pharmacology
Mohammed Aljama
Oncology
Multiple Myeloma Research and Treatments, Cancer Treatment and Pharmacology
Alissa Visram
Oncology
Multiple Myeloma Research and Treatments, Cancer Treatment and Pharmacology
Kylie Lepic
Oncology
Hematopoietic Stem Cell Transplantation
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.